Third Arc Bio announced it raised $72.5 Million in an initial filing from an offering of $165 Million

Company

Location

About

Third Arc Bio's mission is to deliver transformational therapies for solid tumors and I&I diseases in the form of multifunctional antibodies that create immune synapses to precisely activate or inhibit T cells. We have a world class team with a proven track record of success, which positions us well to advance the next generation of highly innovative medicines that redefine the standard-of-care.